Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrotic Interstitial Lungs Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04304898
What this trial is testing

An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology

Who this might be right for
Pulmonary Fibrosis
Erasmus Medical Center 700
Not applicableStudy completedNCT07129707
What this trial is testing

Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)
Dieulefit Santé Centre de Réadaptation 15
Not applicableStudy completedNCT03737409
What this trial is testing

PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial

Who this might be right for
Fibrotic Interstitial Lung Disease
Monash University 116
Early research (Phase 1)Study completedNCT03422068
What this trial is testing

This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 15
Testing effectiveness (Phase 2)Ended earlyNCT02958917
What this trial is testing

Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis

Who this might be right for
Interstitial Lung Disease
Evans Fernandez Perez 40
Not applicableAvailableNCT05356052
What this trial is testing

Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon
Post-approval studies (Phase 4)Study completedNCT05799755
What this trial is testing

Myositis Interstitial Lung Disease Nintedanib Trial

Who this might be right for
Myositis Associated Interstitial Lund Disease (MA-ILD)
Rohit Aggarwal, MD 49
Not applicableEnrolling By InvitationNCT06885515
What this trial is testing

Telomeres Length in Israeli Fibrotic ILD Patients

Who this might be right for
Pulmonary Fibrosis
Barzilai Medical Center 100
Not applicableStudy completedNCT04316780
What this trial is testing

Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes

Who this might be right for
Idiopathic Pulmonary Fibrosis
Steward St. Elizabeth's Medical Center of Boston, Inc. 320
Not applicableUnknownNCT03995654
What this trial is testing

Research of Burden of Interstititial Lung Diseases in Turkey

Who this might be right for
Lung Diseases, InterstitialFibrosis Lung
Karadeniz Technical University 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05983471
What this trial is testing

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisCoughIPF+3 more
Melius Pharma AB 40
Testing effectiveness (Phase 2)UnknownNCT01450644
What this trial is testing

Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease

Who this might be right for
Lung Disease
Royal Marsden NHS Foundation Trust 52
Not applicableStudy completedNCT02044939
What this trial is testing

Pulmonary Rehabilitation in Patients With Sarcoidosis

Who this might be right for
Stage 4 Pulmonary Sarcoidosis
University Hospital, Lille 38
Not applicableNot Yet RecruitingNCT06767904
What this trial is testing

Continuous Versus Demand-Based Oxygen in Patients With Fibrotic Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease

Who this might be right for
Interstitial Lung DiseaseChronic Obstructive Pulmonary Disease
Sissel Kronborg-White 60
Very early researchUnknownNCT04326036
What this trial is testing

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

Who this might be right for
Pulmonary Alveolar ProteinosisCOPDIdiopathic Pulmonary Fibrosis+3 more
Black Tie Medical, Inc. 10
Not applicableStudy completedNCT05779007
What this trial is testing

Dose Reduction and Discontinuation With Anti-Fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 2,778
Not applicableLooking for participantsNCT06732674
What this trial is testing

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Who this might be right for
Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified ElsewhereSystemic Sclerosis PulmonaryDermatomyositis+3 more
Oslo University Hospital 218
Not applicableEnded earlyNCT00415272
What this trial is testing

Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
University of California, San Francisco
Not applicableStudy completedNCT07169253
What this trial is testing

Prognostic Score Comparison in IPF and HP

Who this might be right for
IPFFibrotic Lung DiseaseHypersensitivity Pneumonitis+1 more
Saglik Bilimleri Universitesi 143
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Next Page